Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The percentage of subjects receiving OCA 25 mg that achieved the primary endpoint was 23.8% among those with baseline GLP-1 RA use, 21.6% of those who added a GLP-1 RA, and 22.4% in the overall ITT population, compared to 4.3%, 7.5%, and 9.6% receiving placebo, respectively (Figure 1)
However, it is possible that nerve cell damage will be permanent
It also protects your skin from early ageing and aids in a healthy glow
doi: 10.3233/jad-150096 240
US$ 20.50
US$ 27.17
US$ 26.59
US$ 23.29
US$ 29.47
